SCHEMBL5657737

SCHEMBL5657737

COC(=O)c1cc(OC)c(OC)c2oc(Cc3ccc(-c4ccccc4)cc3)cc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 1/20 0.46
PDE4D Q08499 1/20 0.46
PDE7A Q13946 1/20 0.46
PDE3A Q14432 1/20 0.46
PDE7B Q9NP56 1/20 0.46
ACLY P53396 1/20 0.42
POLB P06746 4/20 0.41
KDM4E B2RXH2 3/20 0.41
HTT P42858 2/20 0.41
ALDH1A1 P00352 1/20 0.41
GAA P10253 1/20 0.41
DHODH Q02127 1/20 0.41
USP2 O75604 1/20 0.40
HSD17B10 Q99714 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NR4A2 P43354 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
NR1H4 Q96RI1 1/20 0.40
ACHE P22303 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5657720 0.93 KDM4E (0.46) PDE4BPDE4DPDE7APDE3APDE7B
SCHEMBL5657121 0.88 MEN1 (0.43) PDE3APOLBKDM4EALDH1A1USP2
SCHEMBL5659101 0.87 SMN1; SMN2 (0.46) POLBKDM4EHTTALDH1A1USP2
SCHEMBL5659646 0.83 SMN1; SMN2 (0.47) PDE4BPDE4DPDE7APDE3APDE7B
SCHEMBL5659115 0.82 TUBB4A (0.41) PDE4BPDE4DPDE7APDE3APDE7B
SCHEMBL5657738 0.82 ALDH1A1 (0.42) PDE4BPDE4DPDE7APDE3APDE7B
SCHEMBL5661034 0.82 ACHE (0.55) PDE4BPDE4DPDE7APDE3APDE7B
SCHEMBL5723113 0.81 PDE4A (0.46) PDE4BPDE4DPOLBKDM4EALDH1A1
SCHEMBL5658621 0.79 KDM4E (0.49) PDE4BPDE4DPOLBKDM4EALDH1A1
SCHEMBL5655596 0.78 KDM4E (0.48) PDE4BPDE4DPOLBKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7030130-B2 Benzofuran derivatives and their use as antibacterial agents ARPIDA AG (CH) 2006-04-18 US disclosed
EP-1307445-B1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS ARPIDA AG (CH) 2005-12-21 EP disclosed
US-20040034047-A1 Benzofuran derivatives and their use as antibacterial agents EVOLVA SA (CH) 2004-02-19 US disclosed
EP-1307445-A1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS Arpida AG, (CH) 2003-05-07 EP disclosed
WO-2002010157-A1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS ARPIDA AG (CH) 2002-02-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034047-A1 Benzofuran derivatives and their use as antibacterial agents SBDS, BPTF, DCXR PDE4B 3190/4885PDE4D 2626/4885PDE7A 3770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.